SCHEMBL1822239

SCHEMBL1822239

COC(CNC(=O)OC(C)(C)C)c1cccc(OS(C)(=O)=O)c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.39
GFER P55789 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NQO2 P16083 1/20 0.36
CA1 P00915 4/20 0.36
CA2 P00918 4/20 0.36
CA12 O43570 3/20 0.36
CA9 Q16790 3/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
MALT1 Q9UDY8 1/20 0.35
ACACB O00763 1/20 0.35
AOC3 Q16853 1/20 0.35
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
ALDH1A1 P00352 1/20 0.34
UTS2R Q9UKP6 1/20 0.34
KDM4A O75164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1826133 0.87 ADRB3 (0.39) SYKGFERHSD17B10L3MBTL1CA1
SCHEMBL1825981 0.86 AOC3 (0.42) SYKL3MBTL1NQO2AOC3
SCHEMBL1826344 0.86 CA12 (0.41) SYKCA1CA2CA12CA9
SCHEMBL1825407 0.86 SYK (0.40) SYKGFERHSD17B10L3MBTL1NQO2
SCHEMBL1827114 0.86 SYK (0.48) SYKCA1CA12CTSSCTSK
SCHEMBL1823878 0.86 GPR17 (0.40) CA1CA2CA12CA9ACACB
SCHEMBL1820861 0.84 SYK (0.41) SYKGFERHSD17B10L3MBTL1NQO2
SCHEMBL1827071 0.84 MTNR1A (0.40) SYKGFERHSD17B10L3MBTL1NQO2
SCHEMBL1822248 0.83 MTNR1A (0.38) SYKGFERHSD17B10L3MBTL1NQO2
SCHEMBL1823955 0.82 SYK (0.41) SYKGFERHSD17B10L3MBTL1NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 SYK 1520/4885GFER 1853/4885HSD17B10 1905/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 SYK 1172/4885GFER 2559/4885HSD17B10 1393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.